17-21 June 2017 Copenhagen
![]() |
![]() |
![]() |
![]() |
1-P | THALASSEMIA CARE IN DHAKA-2016A RETROSPECTIVE, OBSERVATIONAL STUDY OF CHILDREN ATTENDING IN TWO MAJOR THALASSEMIA CENTRES IN DHAKA, BANGLADESHA LOW INCOME COUNTRIES PERSPECTIVE | Amin Islam | ![]() |
![]() |
|||
7-P | LEBANESE RED CROSS BLOOD TRANSFUSION SERVICES: SCALING UP ITS ACTIVITIES TO SATISFY BLOOD NEEDS OF SYRIAN REFUGEES AND HOST POPULATION IN LEBANON | Claudio Zaugg | ![]() |
![]() |
|||
12-P | THE QUANTITATIVE SWOT-ANALYSIS OF ACTIVITY SERVICE BLOOD OF KAZAKHSTAN | Talgat Issayev | ![]() |
![]() |
|||
13-P | IMPLEMENTATION OF COMPUTERIZED BLOOD BANK MANAGEMENT SYSTEMS IN FIVE DEVELOPING SETTINGS: LESSONS LEARNED | Tonderai Mapako | ![]() |
![]() |
|||
16-P | THE RIGHT BLOOD FOR THE RIGHT PATIENT: BRINGING INNOVATION AND TECHNOLOGY TOGETHER | Manuel Algora | ![]() |
![]() |
|||
18-P | VALIDATION OF MULTISOURCE ELECTRONIC HEALTH RECORD DATA: AN APPLICATION TO BLOOD TRANSFUSION DATA | Mart Janssen | ![]() |
![]() |
|||
26-P | TEACHING WITHOUT BORDERS: USING ELEARNING TO IMPROVE CLINICAL TRANSFUSION PRACTICE IN THE DEVELOPING WORLD | David Peterson | ![]() |
![]() |
|||
27-P | THE ROLE OF ELEARNING IN IMPROVING TRANSFUSION PRACTICE AND IMPLEMENTING PBM | David Peterson | ![]() |
![]() |
|||
31-P | DEVELOPMENT OF ORIENTATION PROGRAMME IN BLOOD DONATION AS PART OF KNOWLEDGE MANAGEMENT | Piia Korkalainen | ![]() |
![]() |
|||
38-P | PHENOTYPED RED CELLS MEETING INCREASED DEMAND | Tanya Powley | ![]() |
![]() |
|||
80-P | A WEB-BASED APPROACH TO BLOOD DONOR MANAGEMENT IN HOSPITAL BLOOD BANK | Svetlana Trofimova | ![]() |
![]() |
|||
86-P | RETROSPECTIVE ANALYSIS OF CAPILLARY HEMOGLOBIN RECOVERY IN NEARLY 1 200 000 BLOOD DONOR RETURNS | Mikko Arvas | ![]() |
![]() |
|||
87-P | THE INFLUENCE OF TELEPHONE CONTACTING ON THE RETURN OF FIRST-TIME DONORS | Anu Keisala | ![]() |
![]() |
|||
126-P | CAN HISTORICAL DONOR PLATELET COUNTS RESULTS BE USED FOR PROGRAMMING PLATELET DONATION? | Phillip Mondy | ![]() |
![]() |
|||
127-P | FIFTY YEARS OF RHD IMMUNOGLOBULIN THERAPY IN AUSTRALIA | Tanya Powley | ![]() |
![]() |
|||
130-P | BLOOD DONORS PERCEPTION ON ABO BLOOD TYPE BASED MANAGEMENT AND ITS INFLUENCE ON INTENTION TO DONATE | Elina Palokangas | ![]() |
![]() |
|||
142-P | COLLECTION OF BLOOD COMPONENTS BY APHERESIS IN THE RUSSIAN FEDERATION | Alexander Chechetkin | ![]() |
![]() |
|||
146-P | IMPROVING SAFETY AND ENHANCING THE DONATION EXPERIENCE FOR APHERESIS DONORS | Barbara Bell | ![]() |
![]() |
|||
147-P | 11 OF FINNISH BLOOD DONOR HAVE IRON DEFICIENCY BUT THEIR SELF-REPORTED SUBJECTIVE HEALTH IS NOT AFFECTED | Pia Niittymki | ![]() |
![]() |
|||
156-P | THE CRUCIAL ROLE OF BLOOD COLLECTION STAFF IN PREVENTING AND MANAGING VASOVAGAL REACTIONS | Amanda Thijsen | ![]() |
![]() |
|||
168-P | MAXIMISING PLATELET USAGE BY DELAYING REFRIGERATED STORAGE | Denese Marks | ![]() |
![]() |
|||
197-P | IMPROVED BACTERIAL DETECTION ALGORITHM SUPPORTS EXTENSION OF PLATELET STORAGE FROM 5 TO 7 DAYS AT CANADIAN BLOOD SERVICES | Sandra Ramirez-Arcos | ![]() |
![]() |
|||
201-P | CRYOPRESERVED PLATELETS DEMONSTRATE A REDUCED RESPONSE TO COLLAGEN STIMULATION | Denese Marks | ![]() |
![]() |
|||
208-P | FIVE YEARS FOLLOW UP OF BLOOD PRODUCTS QUALITY CONTROL AT THE ETABLISSEMENT FRANAIS DU SANG, THE FRENCH TRANSFUSION PUBLIC SERVICE | Stephane Bégué | ![]() |
![]() |
|||
212-P | NUMERICAL INVESTIGATION OF RED BLOOD CELL MEMBRANE MECHANICAL PROPERTIES AND DEFORMABILITY DURING INDENTATION | Sarah Barns | ![]() |
![]() |
|||
219-P | CORRELATION BETWEEN ABSENCE OF SWIRLING IN PLATELETS CONCENTRATES AND BIOCHEMICAL CHANGES IN METABOLISM | Nicolas de Valensart | ![]() |
![]() |
|||
224-P | EVIDENCE BASED PRACTICE OF FRESH FROZEN PLASMA REPEAT FREEZE THAW | Hanna Morani | ![]() |
![]() |
|||
244-P | OXYGEN CONTENT--UNCONTROLLED AND OVERLOOKED PARAMETER ASSOCIATED WITH STORED RED CELL CONCENTRATE QUALITY: UNEXPECTEDLY WIDE DISTRIBUTION | Tatsuro Yoshida | ![]() |
![]() |
|||
250-P | CHARACTERIZATION OF INTERCEPT BLOOD SYSTEM FOR RED BLOOD CELLS USING SAGM RBCS PREPARED USING MANUAL AND AUTOMATED WHOLE BLOOD SEPARATION TECHNIQUES | Lynn Annandale | ![]() |
![]() |
|||
252-P | INACTIVATION OF BIOFILM-DERIVED STAPHYLOCOCCUS EPIDERMIDIS IN PLATELET CONCENTRATES WITH RIBOFLAVIN AND ULTRAVIOLET LIGHT TREATMENT | Sandra Ramirez-Arcos | ![]() |
![]() |
|||
254-P | RED BLOOD CELL CONCENTRATES TREATED WITH THE AMUSTALINE (S-303) PATHOGEN REDUCTION SYSTEM RETAIN ERYTHROCYTE MORPHOLOGY AND METABOLIC PROPERTIES | Catherine RAVANAT | ![]() |
![]() |
|||
256-P | ROBUSTNESS OF THE INTERCEPT BLOOD SYSTEM FOR RED BLOOD CELLS | Lynn Annandale | ![]() |
![]() |
|||
258-P | ZIKA VIRUS INFECTIVITY IS REDUCED FOLLOWING TREATMENT WITH THE THERAFLEX UVC-PLATELET AND THERAFLEX MB-PLASMA SYSTEMS | Denese Marks | ![]() |
![]() |
|||
259-P | EVALUATION OF APHERESIS PLATELETS PROCESSED WITH THE INTERCEPT BLOOD SYSTEM FOR PLATELETS TRIPLE STORAGE SET | Lynn Annandale | ![]() |
![]() |
|||
262-P | EVALUATION OF PATHOGEN REDUCED (AMOTOSALEN-UVA) POOLED CRYOPRECIPITATE AND CRYOPRECIPITATE-POOR PLASMA | Lynn Annandale | ![]() |
![]() |
|||
269-P | FEASIBILITY TEST OF DOUBLE DOSES PATHOGEN-REDUCED PLATELET COMPONENTS BY INTERCEPT BLOOD SYSTEM AFTER SEPARATION FROM WHOLE BLOOD BY REVEOS AUTOMATED BLOOD PROCESSING SYSTEM | Mohammad Reza Abedi | ![]() |
![]() |
|||
273-P | EFFECTIVENESS OF AMOTOSALEN/UVA LIGHT PATHOGEN-REDUCED PLATELETS TRANSFUSED TO ADULT PATIENTS | Railya Ayupova | ![]() |
![]() |
|||
275-P | EFFECTIVE PATHOGEN INACTIVATION IN TRIPLE SET KITS FOR PLATELETS SUSPENDED IN PLATELET ADDITIVE SOLUTION (PASIII) | Lynn Annandale | ![]() |
![]() |
|||
277-P | PRODUCTION AND QUALITY OF ALLOGENEIC PLATELET GEL PRODUCED BY PRECIPITATION OF EXPIRED APHERESIS PLATELET CONCENTRATES | Denese Marks | ![]() |
![]() |
|||
278-P | AUTOLOGOUS SERUM EYE DROPS: FIVE YEARS EXPERIENCE OF MANUFACTURING AND APPLICATION | Melanie Strmer | ![]() |
![]() |
|||
288-P | ROBUSTNESS OF THE ABBOTT PRISM METHODS TO BIOTIN INTERFERENCE | Lynn Martin | ![]() |
![]() |
|||
289-P | SPECIFICITY OF AUTOMATED BLOOD SCREENING ASSAYS DEVELOPED FOR THE NEW ABBOTT ALINITY S SYSTEM | Lynn Martin | ![]() |
![]() |
|||
293-P | PERFORMANCE CHARACTERISTICS OF THE 4 SCREENING ASSAYS, HBSAG QUALITATIVE II, ANTI-HCV, HIV AG/AB COMBO AND SYPHILIS TP ON ABBOTTS NEW ALINITY I SYSTEM | Angela Vockel | ![]() |
![]() |
|||
331-P | PERFORMANCE OF A NEW AUTOMATED ASSAY FOR HEPATITIS B SURFACE ANTIGEN AND HEPATITIS B SURFACE ANTIGEN CONFIRMATORY ON THE ALINITY S SYSTEM | Lynn Martin | ![]() |
![]() |
|||
336-P | PERFORMANCE OF NEW AUTOMATED IMMUNOASSAY ASSAY FOR ANTI-HBC ON THE ALINITY S SYSTEM | Lynn Martin | ![]() |
![]() |
|||
339-P | PERFORMANCE OF A NEW AUTOMATED ASSAY FOR ANTI-HCV FOR THE ALINITY S SYSTEM | Lynn Martin | ![]() |
![]() |
|||
363-P | PERFORMANCE OF NEW AUTOMATED IMMUNOASSAY ASSAY FOR HIV ON THE ALINITY S SYSTEM | Lynn Martin | ![]() |
![]() |
|||
368-P | PERFORMANCE OF A NEW AUTOMATED IMMUNOASSAY FOR THE DETECTION OF SYPHILIS ON THE ALINITY S SYSTEM | Lynn Martin | ![]() |
![]() |
|||
375-P | PERFORMANCE OF A NEW AUTOMATED ASSAY FOR ANTIBODIES TO T. CRUZI ON THE ALINITY S SYSTEM | Lynn Martin | ![]() |
![]() |
|||
379-P | PERFORMANCE AND EVALUATION OF PROCLEIX ZIKA VIRUS ASSAY ON THE FULLY AUTOMATED PROCLEIX PANTHER SYSTEM | Kui Gao | ![]() |
![]() |
|||
386-P | ROBUST INACTIVATION OF DUCK HEPATITIS B VIRUS WITH AMUSTALINE/GSH IN WHOLE BLOOD | Lynn Annandale | ![]() |
![]() |
|||
389-P | PERFORMANCE OF A NEW AUTOMATED ASSAY FOR ANTIBODIES TO CMV ON THE ALINITY S SYSTEM | Lynn Martin | ![]() |
![]() |
|||
397-P | PERFORMANCE OF A NEW AUTOMATED IMMUNOASSAY FOR THE DETECTION OF HTLV I AND HTLV II ON THE ALINITY S SYSTEM | Lynn Martin | ![]() |
![]() |
|||
402-P | PREVENTING EMERGING AND CO-CIRCULATING TRANSFUSION-TRANSMITTED ARBOVIRUS INFECTIONS | didier musso | ![]() |
![]() |
|||
404-P | HEPATITIS E VIRUS INFECTION: INCIDENCE AND EPIDEMIOLOGICAL CHARACTERISTICS OF POSITIVE BLOOD DONORS IN CATALONIA (SPAIN) | Maria Piron | ![]() |
![]() |
|||
414-P | A NOVEL ADJUNCT AUTOMATED BLOOD BANK METHOD TO MANAGE INTERFERENCE FROM THE MONOCLONAL ANTI-CD38 DRUG DARATUMUMAB. | Glenda Mann | ![]() |
![]() |
|||
450-P | PREDICTING ANTI-RHD TITERS IN DONORS: BOOSTERING RESPONSE AND DECLINE RATES ARE PERSONAL | Mart Janssen | ![]() |
![]() |
|||
453-P | DEVELOPMENT AND APPLICATION OF ETERNAL BLOOD GROUP ANTIGENS INDEPENDENT OF LIVING RED CELLS | Shengbao Duan | ![]() |
![]() |
|||
462-P | THE MDMULTICARD FOR TYPING FYA, FYB, JKA, JKB, S, AND LITTLE S WAS SUPERIOR TO THE TUBE METHOD | Christof Weinstock | ![]() |
![]() |
|||
474-P | EVALUATION STUDY OF THE ERY SPOT WEAK D-TYPE GENOTYPING ASSAY ON THE MR.SPOT PROCESSOR | rolf marell | ![]() |
![]() |
|||
501-P | AN RHDC.1066 INS A MUTATION INDUCES PARTIAL D REACTIVITY | Brigitte Flesch | ![]() |
![]() |
|||
511-P | A THIRD ABO ALLELE IN A PATIENT WITH TRISOMIE 9 | Brigitte Flesch | ![]() |
![]() |
|||
513-P | AN ABO MOLECULAR TYPING ENIGMA | Franz Wagner | ![]() |
![]() |
|||
519-P | A FUT1C.787INSA MUTATION INDUCES A PREMATURE STOP AND THE BOMBAY (H-) PHENOTYPE | Brigitte Flesch | ![]() |
![]() |
|||
526-P | A NOVEL KLF1 ALLELE LEADING TO AN IN(LU) PHENOTYPE | Christine Henny | ![]() |
![]() |
|||
552-P | THE DETECTION OF MATERNAL HPA-1A ANTIBODIES AND THEIR ROLE IN PREDICTING THE SEVERITY OF FNAIT: A SYSTEMATIC REVIEW | Denise Landry | ![]() |
![]() |
|||
586-P | RED BLOOD CELL ANTIBODIES AND HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN IN ISRAEL WHAT IS THE EVIDENCE? | Naomi Rahimi-Levene | ![]() |
![]() |
|||
588-P | FETOMATERNAL RED BLOOD CELLS ALLOIMMUNIZATION AND UNIVERSAL CORD BLOOD SCREENING AT BIRTH: ONE-CENTER EXPERIENCE | Elena Lazarova | ![]() |
![]() |
|||
589-P | ANALYSIS OF PEDIATRIC ADVERSE REACTIONS TO TRANSFUSIONS (APART) | Sarah Vossoughi | ![]() |
![]() |
|||
621-P | INCREASING PREVALENCE OF ANEMIA AFTER HOSPITAL DISCHARGE AND LONG TERM CLINICAL OUTCOMES | Nareg Roubinian | ![]() |
![]() |
|||
626-P | QUALITY OF EVIDENCE-BASED GUIDELINES FOR TRANSFUSION OF RED BLOOD CELLS AND PLASMA: A SYSTEMATIC REVIEW | Denise Landry | ![]() |
![]() |
|||
629-P | SICKLE CELL DISEASE: THE ADVANTAGES OF PHENOTYPE COMPATIBLE RED CELLS AND UTILITY OF GENOTYPING IN ERTHROCYTAPHERESIS | Danielle Clucas | ![]() |
![]() |
|||
634-P | TRANSFUSION REQUIREMENTS OF PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TANSPLANTATION FROM DIFFERENT STEM CELL SOURCES AND MODALITIES | Pilar Solves | ![]() |
![]() |
|||
642-P | APPROPRIATENESS OF PLATELET USE IN MATER DEI HOSPITAL, MALTA | Denise Borg-Aquilina | ![]() |
![]() |
|||
645-P | RED CELL SPECIFICATIONS FOR PATIENTS WITH HEMOGLOBINOPATHIES: A SYSTEMATIC REVIEW AND GUIDELINE | Denise Landry | ![]() |
![]() |
|||
657-P | MASSIVE TRANSFUSION: FEEDBACK ON PRACTICE THROUGH HOSPITAL DATA REPORTS PROVIDES OPPORTUNITIES FOR PRACTICE IMPROVEMENT AND BENCHMARKING | Erica Wood | ![]() |
![]() |
|||
668-P | CHALLENGES IN THE EVALUATION OF RECIPIENT PULMONARY EVENTS--THE EXPERIENCE OF A LARGE COLLECTION ORGANIZATION | Mary Townsend | ![]() |
![]() |
|||
683-P | HAEMOLYTIC DISEASE OF FOETUS AND NEWBORN (HDFN) AND HAEMOLYTIC TRANSFUSION REACTION DUE TO KIDD ANTIBODY IN HOSPITAL UMUM SARAWAK, MALAYSIA. | Irni Mohd Yasin | ![]() |
![]() |
|||
699-P | THE FIRST PRELIMINARY STEP TOWARDS NATIONAL HEMOVIGILANCE IN LEBANON | Antoine HADDAD | ![]() |
![]() |
17-21 June 2017 Copenhagen
![]() |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. ![]() To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. ![]() |
![]() |
||
![]() |
|